Stock Financial Ratios, Dividends, Split History

KATE / Kate Spade & Company financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)2,377.90
Book Value ($M)436.32
Book Value / Share3.39
Price / Book5.45
NCAV / Share5.86
Price / NCAVn/a
Share Statistics
Weighted Average Number Of Shares Outstanding Basic 128,043,000
Weighted Average Number Of Diluted Shares Outstanding 129,164,000
Common Shares Outstanding 128,291,120
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)n/a
Return on Assets (ROA)n/a
Return on Equity (ROE)n/a
Balance Sheet (mrq) ($M)
Quick Ratio2.59
Current Ratio3.66
Income Statement (mra) ($M)
Sales Revenue Goods Net1,381,478,000.00
Operating Income183.61
Earnings Per Share Diluted1.19
Earnings Per Share Basic1.20
Cash Flow Statement (mra) ($M)
Cash From Operations244.89
Cash from Investing-59.24
Cash from Financing-59.24
Identifiers and Descriptors
Central Index Key (CIK)352363
Related CUSIPS
485865909 048586510 485865959

Split History

Stock splits are used by Kate Spade & Company to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

Admin, opposition united for mental healthcare

For Filipinos struggling with mental health problems in their families and communities alone and in silence, help is here. (7-0)

Kate Spade Foundation to donate $1 million for suicide prevention

2018-06-20 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: (7-0)

Jump In On Ultra-Luxury?

2018-06-18 seekingalpha
Consumers crave brand names. Whether they have the willingness or ability to pay for it, we seek items that make us feel good and elevate our social status. The luxury scene has exploded, and American brands including Michael Kors, Coach, Kate Spade, Ralph Lauren, and Calvin Klein seem to be more and more prevalent every year as increasing amounts of consumers seem to be toting around recognizable handbags or wearing branded shirts. (12-0)

Filipino chefs mourn idol Anthony Bourdain who inspired them

NEW YORK — Filipino chefs in NYC are mourning the death of celebrity chef and travel writer Anthony Bourdain who, according to news reports, hanged himself June 8 in a hotel in France. (7-0)

My Mom’s Suicide Was Preventable - WSJ

2018-06-14 wsj
I didn’t know Kate Spade or Anthony Bourdain but saw familiar threads in their suicides, as my mother took her own life at age 51. (7-0)

CUSIP: 485865109